0001288123-18-000019.txt : 20180702
0001288123-18-000019.hdr.sgml : 20180702
20180702152123
ACCESSION NUMBER: 0001288123-18-000019
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180702
FILED AS OF DATE: 20180702
DATE AS OF CHANGE: 20180702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JORDAN WADIH
CENTRAL INDEX KEY: 0001222090
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-29089
FILM NUMBER: 18932455
MAIL ADDRESS:
STREET 1: ANTIGENICS INC.
STREET 2: 162 FIFTH AVE., SUITE 900
CITY: NEW YORK
STATE: NY
ZIP: 10010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AGENUS INC
CENTRAL INDEX KEY: 0001098972
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 061562417
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-674-4410
MAIL ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIGENICS INC /DE/
DATE OF NAME CHANGE: 19991115
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2018-07-02
0
0001098972
AGENUS INC
AGEN
0001222090
JORDAN WADIH
AGENUS INC.
149 FIFTH AVE., SUITE 500
NEW YORK
NY
10010
1
0
0
0
Deferred Shares
3.434
2018-07-02
4
A
0
5095.773
3.434
A
Common Stock
5095.773
5095.773
D
Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.
Christine M. Klaskin, by Power of Attorney
2018-07-02